Abstract:Physiologically based pharmacokinetic (PBPK) models are scientific methods used to predict veterinary drug residues that may occur in food-producing animals, and which have powerful extrapolation ability. Quinocetone (QCT) and mequindox (MEQ) are widely used in China for the prevention of bacterial infections and promoting animal growth, but their abuse causes a potential threat to human health. In this study, a flow-limited PBPK model was developed to simulate simultaneously residue depletion of QCT and its marker residue dideoxyquinocetone (DQCT) in pigs. The model included compartments for blood, liver, kidney, muscle and fat and an extra compartment representing the other tissues. Physiological parameters were obtained from the literature. Plasma protein binding rates, renal clearances and tissue/plasma partition coefficients were determined by in vitro and in vivo experiments. The model was calibrated and validated with several pharmacokinetic and residue-depletion datasets from the literature. Sensitivity analysis and Monte Carlo simulations were incorporated into the PBPK model to estimate individual variation of residual concentrations. The PBPK model for MEQ, the congener compound of QCT, was built through cross-compound extrapolation based on the model for QCT. The QCT model accurately predicted the concentrations of QCT and DQCT in various tissues at most time points, especially the later time points. Correlation coefficients between predicted and measured values for all tissues were greater than 0.9. Monte Carlo simulations showed excellent consistency between estimated concentration distributions and measured data points. The extrapolation model also showed good predictive power. The present models contribute to improve the residue monitoring systems of QCT and MEQ, and provide evidence of the usefulness of PBPK model extrapolation for the same kinds of compounds.

Tissue Depletion of Quinocetone and Its Five Major Metabolites in Pigs, Broilers, and Carp Fed Quinocetone Premix.

Metabolic Disposition and Excretion of Quinocetone in Rats, Pigs, Broilers, and Carp

The Metabolites of Quinocetone in Pigs

Metabolism Profile of Quinocetone in Swine by Ultra-Performance Liquid Chromatography Quadrupole Time-of-flight Mass Spectrometry

Tissue Depletion of Olaquindox and Its Six Metabolites in Pigs and Broilers: Identification of a Suitable Marker Residue

Identification of the Major Metabolites of Quinocetone in Swine Urine Using Ultra-Performance Liquid Chromatography/electrospray Ionization Quadrupole Time-of-flight Tandem Mass Spectrometry.

Development of Liquid Chromatographic Methods for Determination of Quinocetone and Its Main Metabolites in Edible Tissues of Swine and Chicken.

Metabolism, Distribution, and Elimination of Mequindox in Pigs, Chickens, and Rats

Distribution and elimination of quinocetone and its major metabolites in Cherry Valley ducks.

Physiologically based pharmacokinetic model for quinocetone in pigs and extrapolation to mequindox.

Pharmacokinetics and Tissue Distribution of Quinocetone in Carp and Channel Catfish

Acute and sub-chronic oral toxicological evaluations of quinocetone in Wistar rats.

Plasma Pharmacokinetics of Quinocetone in Ducks after Oral and Intravenous Administration

Progress on Food Safety Evaluation for Quinocetone

Dietary Exposure Assessment Of Cyadox Based On Tissue Depletion Of Cyadox And Its Major Metabolites In Pigs, Chickens, And Carp

Metabolism and Tissue Depletion of Carbadox in Swine, Broilers, and Rats

Residue Depletion and Tissue-Plasma Correlation of Methyl-3-Quinoxaline-2-Carboxylic Acid after Dietary Administration of Olaquindox in Pigs

Residue depletion of cefquinome in swine tissues after intramuscular administration.

Investigation of quinocetone-induced genotoxicity in HepG2 cells using the comet assay, cytokinesis-block micronucleus test and RAPD analysis.

Tissue residues and withdrawal time of moxidectin treatment of swine by topical pour-on application

HPLC Determination of Quinocetone in Chicken Tissues